SOURCE: TheraBiogen, Inc.

July 06, 2011 08:30 ET

TheraBiogen, Inc. Announces Agreement for International Distribution Representation.

NEW YORK, NY--(Marketwire - Jul 6, 2011) - TheraBiogen, Inc. (OTCBB: TRAB) today announced an agreement for sales representation and distribution of its Thera Maxhomeopathic nasal sprays for aiding in relief of allergies, cold and flu symptoms and migraine headaches for Latin America, the Caribbean and specific European countries.

TheraBiogen has selected CLADD Holdings Corporation (CLADD), headquartered in Miami, Florida to exclusively represent TheraBiogen, Inc. in Latin America, the Caribbean and certain countries and accounts in Europe and to set up resellers and distributors in those areas. "We are very excited to have a world class organization like CLADD Holdings Corporation represent us in these areas as we expand the distribution of the Thera Maxproduct line to the international arena," said Kelly T. Hickel, CEO of TheraBiogen. "We are pleased to be selected as the exclusive representative of TheraBiogen products in the assigned territories. These products will add depth to our product line and we look forward to bringing TheraBiogen products into our international locations," said Marcelo Kochen, CEO of CLADD Holdings Corporation.

Thera Max is available for purchase in the United States in thousands of locations from Rite-Aid, Walgreens Miami South District, Hannaford Supermarkets, Discount Drug Marts and Big Y Supermarkets. For more information on Thera Max visit our website or our Facebook page at

About TheraBiogen, Inc.
TheraBiogen, Inc. are manufacturers and distributors of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. For further information please visit

About CLADD Holdings Corporation
CLADD Holdings is an international firm based in Miami, Florida consisting of expert management, associates and affiliates with hands on experience in helping businesses in a plethora of industries. We understand how to cost efficiently take a product from "print on paper" to a thriving business by partnering with companies whose products and services are in close synergy with our platform, whether in the domestic or international arena. For further information please visit

Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company's most recently filed form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.

Contact Information

  • Company Contact:
    TheraBiogen, Inc.
    Kelly T. Hickel
    Chairman and CEO
    Email Contact

    CLADD Holdings Corporations
    Marcelo Kochen
    Email Contact